ICLR
ICON plc
NASDAQ · Healthcare · Medical - Diagnostics & Research · IE
$168.14
−1.20%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$169.25
From 52W high−17.14%
Volume728527.00
Market cap$12.97B
P/E (TTM)39.2x
P/S (TTM)1.6x
Div yield—
Key dataOct 19, 2026
Open
$169.25
From 52W high
−17.14%
Volume
728527.00
Market cap
$12.97B
ValuationView details →
P/E (Fwd)
14.7x
EV/EBITDA
12.5x
P/E (TTM)
39.2x
RSI (14)
51.5
MomentumView details →
1D Return
−1.20%
YTD Return
−7.43%
SummaryUpdated Jun 1, 2026
ICON Public Limited Company (NASDAQ:ICLR) is a Dublin-based clinical research organization that was founded in 1990 and went public in 1998. The company provides comprehensive outsourced development and commercialization services to pharmaceutical, biotechnology, and medical device companies worldwide. ICON has grown significantly through strategic acquisitions, most notably its 2021 merger with PRA Health Sciences, which transformed it into one of the world's largest contract research organizations. Today, ICON operates globally with a particular strength in supporting clinical trials from early-phase development through post-market surveillance.
Similar companies
Latest newsMore news →